Our principles

Principles that guide how we work

SysGene is guided by a clear purpose and a responsible, evidence-led approach to developing technologies, products and partnerships.

Mission

To assist patient populations through our clients, in improving access to essential products, through cost reductions utilising our platforms enabling faster, more efficient and scalable approaches to development and manufacturing of drug substances.

Vision

Through scientific rigor, collaboration and transparency to become a trusted development, scale up and manufacturing partner or technology-transfer partner for key GMP & non-GMP molecules for biologic entities and peptides.

Quality

We strive to achieve safe, compliant and reliable development and manufacturing services, through continuous improvement, regulatory excellence, data integrity, with our GMP standards based on ICH Q10 guidelines. Our aim is to enable our clients to bring life-changing therapies to patients worldwide.

Environmental responsibility

We are committed to minimizing the environmental impact of our operations through responsible use of energy, water and raw materials, prevention of pollution, reduction of waste and greenhouse gas emissions, compliance with applicable environmental regulations, and continuous improvement of our environmental performance.

Ethical business practices

We are committed to operating our business through Codes of Conduct, which comply with applicable laws and regulations, respecting human rights, protecting confidential information, and maintaining integrity and transparency throughout every partnership.

Health & Safety

At SysGene the health, safety, and wellbeing of our employees, contractors, visitors, customers, and the communities in which we operate are fundamental to our success. We are committed to maintaining a safe, healthy, and sustainable working environment across all development, manufacturing, laboratory, and support operations.

See the evidence behind our platforms

Quality standards

The guidelines and grades we work to

Quality is built into how SysGene develops processes, characterizes molecules and supplies products.

ICH-aligned development

Development, characterization and analytical activities are aligned with the International Council for Harmonisation (ICH) guidelines for biotechnological products, including ICH Q6B (specifications and characterization), ICH Q5E (comparability) and ICH Q2(R2) (validation of analytical procedures). Our GMP standards are based on ICH Q10.

Product grades

SysGene products are manufactured to the requirements of their stated grade, research grade, multi-compendial or GMP. The applicable grade and its supporting documentation are confirmed for each product.

Multi-compendial standards

Multi-compendial products are specified against the relevant monographs of more than one pharmacopoeia, such as the United States Pharmacopeia (USP), European Pharmacopoeia (Ph. Eur.) and Japanese Pharmacopoeia (JP).

Documented evidence

Technical information is classified as a validated specification, representative result, development target or external benchmark, so the strength of each claim is clear.

Scientist examining a sample under a microscope in a laboratory

Leadership

The team behind SysGene

Portrait of Andrew Mitchell

Andrew Mitchell

Chief Executive Officer

Portrait of JC Pavan Reddy

JC Pavan Reddy

Director

Portrait of Nisheeth Rao Juvvadi

Nisheeth Rao Juvvadi

Director

Manufacturing capability

Capacity in Hyderabad

SysGene operates in-house mammalian bioreactor capacity at 5 L scale and microbial fermenters from development scale to 30 L, 100 L, and 1,000 L in Hyderabad, with 5,000 L capacity planned. Programs may be scoped for GMP or non-GMP manufacture, subject to facility, product and regulatory fit. Additional capacity and specialized capabilities may be delivered through qualified partners.

Discuss a partnership

Tell us about the programme or product requirement and we will route your enquiry to the right team.

Contact SysGene